due very soon help me please

Screen Shot 2019-07-31 at 12.16.56 PM Q Search 1. PR.13-01.ALGO (Algorithmic) Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, Dec. 31, + 203 20Y2 Assets Cash $294,560 $274,640 ep Accounts receivable (net) 106,710 98,640 Inventories 301,230 292,060 Investments 113,140 Land 154,510 as 1 Equipment 332,350 258,200 Accumulated depreciation-equipment (77,810) (69,630) Total assets $1,111,550 $967,050 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $201,190 $190,510 Accrued expenses payable (operating expenses) 20,010 25,140 Dividends payable 8,700 11,120 rom Common stock, $10 par 60,020 47,390 Sthot 3.46 PMA 2018-11